Stereotaxis STXS
NYSE STXS
$1.42 -0.02 (-1.39%)
At close: Aug 21, 2026 · 4:00 PM EDT

Stereotaxis (STXS) Receivables - Other (2010 - 2026)

Stereotaxis (STXS) posted quarterly Receivables - Other of $4.3 million for Q1 2026, little changed quarter-over-quarter from $4.3 million in Q4 2025.

Stereotaxis (STXS) Receivables - Other (2010 - 2026) Analysis & Trends

Stereotaxis (STXS) has reported Receivables - Other for 9 consecutive years, with $4.3 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Receivables - Other changed N/A year-over-year to $4.3 million; the TTM figure through Mar 2026 stood at $4.3 million (changed N/A YoY), while the FY2025 annual figure was $4.3 million, changed N/A from the prior year.
  • Receivables - Other held at $4.3 million in Q1 2026 per STXS's latest filing, from $4.3 million in the prior quarter.
  • Across five years, Receivables - Other topped out at $4.3 million in Q4 2025 and bottomed at $4.3 million in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Intuitive Surgical 134.13 Bn 128.91 Bn 1.96 Bn
2 Becton Dickinson 52.76 Bn 51.90 Bn 2.32 Bn
3 Alcon 35.81 Bn 34.46 Bn 1.68 Bn
4 Resmed 33.72 Bn 32.25 Bn 861.22 Mn
5 Medline 29.38 Bn 26.70 Bn 2.22 Bn
6 West Pharmaceutical Services 25.00 Bn 24.57 Bn 329.20 Mn
7 Solventum 15.46 Bn 15.06 Bn 1.29 Bn
8 Cooper Companies 14.88 Bn 14.74 Bn 735.40 Mn
9 Baxter International 13.58 Bn 11.43 Bn 1.03 Bn
10 Stereotaxis 141.91 Mn 127.29 Mn 3.79 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 6.32 Mn
Jun 30, 2026 6.32 Mn
Mar 31, 2026 4.32 Mn
Mar 31, 2026 4.32 Mn
Dec 31, 2025 4.32 Mn
Dec 31, 2025 4.32 Mn
Dec 31, 2019 168,445.00
Dec 31, 2019 168,445.00
Dec 31, 2018 251,867.00
Dec 31, 2018 251,867.00
Mar 31, 2014 -21,305.00
Mar 31, 2014 -21,305.00
Dec 31, 2013 695.00
Dec 31, 2013 695.00
Sep 30, 2013 695.00
Sep 30, 2013 695.00
Jun 30, 2013 847.00
Jun 30, 2013 847.00
Mar 31, 2013 -54,064.00
Mar 31, 2013 -54,064.00